Overview
This study aims to investigate outcomes and predictors of outcome after extracorporeal membrane oxygenation (ECMO) therapy for severe acute respiratory syndrome (ARDS) in COVID-19 patients.
Eligibility
Inclusion Criteria:
- PCR-confirmed or suspected COVID-19 infection with ARDS who require any ECMO therapy
Exclusion Criteria:
- None